KLAC
45
3
AEE
51
3
CMCSA
49
3
V
70
14
WAT
55
11
AAP
26
5
EOG
28
2
HUM
25
4
R
55
-2
HSY
32
3
ALL
37
3
TXN
29
4
CHRW
53
2
EA
41
3
IR
46
3
COF
48
3
DFS
64
4
TAP
57
6
INTC
35
4
AMAT
33
3
KLAC
45
3
AEE
51
3
CMCSA
49
3
V
70
14
WAT
55
11
AAP
26
5
EOG
28
2
HUM
25
4
R
55
-2
HSY
32
3
ALL
37
3
TXN
29
4
CHRW
53
2
EA
41
3
IR
46
3
COF
48
3
DFS
64
4
TAP
57
6
INTC
35
4
AMAT
33
3
Financhill
Back

Axsome Therapeutics 10K Form

Sell
33

AXSM
Axsome Therapeutics

Last Price:
$90.86
Seasonality Move:
22.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXSM News And Ratings

See the #1 stock for the next 7 days that we like better than AXSM

AXSM Financial Statistics

Sales & Book Value

Annual Sales: $270.6M
Cash Flow: $-18.7M
Price / Cash Flow: 0
Annual Sales: $1.92
Price / Book: 47.36

Profitability

EPS (TTM): -6.53000
Net Income (TTM): $-311M
Gross Margin: $244.5M
Return on Equity: -194.28%
Return on Assets: -54.66%

Axsome Therapeutics Earnings Forecast

Key Axsome Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 4 years for AXSM is 90.37%.
  • The Selling, General & Administrative Expenses for AXSM have been equal to 119.41% of Gross Profit Margin.
  • The Research & Development expenses have been 36.20% of Revenue.
  • The Interest Expense is -2.70% of Operating Income.
  • The Net Earning history of AXSM is -88.41% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 2 years.

Axsome Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AXSM
CUSIP: 05464T
Website: axsome.com

Debt

Debt-to-Equity Ratio: 1.94
Current Ratio: 2.44
Quick Ratio: 2.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AXSM Technical Analysis vs Fundamental Analysis

Sell
33
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy or a Sell?